New Study Finds Elevated PFAS Toxin Exposure in Umbilical Cord Blood

A newly published study in Environmental Science & Technology is raising urgent concerns about prenatal PFAS exposure after researchers identified far more “forever chemicals” in umbilical cord blood than previously recognized. 

The study, conducted by researchers at the Icahn School of Medicine at Mount Sinai and published in Environmental Science & Technology, used advanced non-targeted chemical analysis to evaluate stored cord blood samples from infants born between 2003 and 2006. Instead of testing for a limited list of compounds, researchers screened broadly — identifying 42 confirmed or suspected PFAS chemicals present at birth. 

The findings suggest that fetal exposure to environmental toxins may be significantly under recognized. 

What the Science Revealed About PFAS in Pregnancy 

Per- and polyfluoroalkyl substances (PFAS) are synthetic chemicals found in nonstick cookware, stain-resistant fabrics, food packaging, and firefighting foam. Often referred to as “forever chemicals,” they accumulate in both the environment and human tissue due to their resistance to degradation. 

Using a novel PFAS-omics burden score, researchers were able to measure cumulative exposure rather than isolated compounds. This broader testing approach revealed: 

• A greater number of PFAS chemicals present in cord blood than traditional panels detect 

• Evidence of placental transfer of multiple compounds 

• No significant difference in total PFAS burden between first-time mothers and those with prior pregnancies when measured comprehensively 

Prior research has linked prenatal PFAS exposure to lower birth weight, preterm birth, immune system changes, altered vaccine response, and metabolic disruptions. The American College of Obstetricians and Gynecologists has previously identified reduction of environmental toxin exposure as a critical area of intervention during pregnancy. 

The Implications of Maternal Toxic Burden 

Pregnancy represents one of the most sensitive windows for environmental toxin exposure. The placenta does not act as a complete barrier; rather, it facilitates nutrient exchange — and unfortunately, chemical transfer. 

Dr. Lisa Semple of MDLifespan emphasizes the broader implications of this research: 

“This type of research is so important as we navigate through increased environmental toxic exposure. It appears to be imperative that we consider the exposure of the fetus in utero, not only in regard to growth and development but also long-term effects into teenage and adult years. 

More studies are necessary to truly find the correlations between fetal risk and maternal toxic burden, but it is evident that toxins are transported between mother and fetus via placental transfer. Education is key, avoidance is necessary and most importantly, guidance needs to be based in support rather than fear and guilt.” 

 

The takeaway is not fear — but proactive, informed prevention. 

Moving Toward Prevention: Optimizing the Internal Environment Before Pregnancy 

As data continues to evolve, many women are seeking ways to reduce toxin exposure and lower inflammatory burden prior to conception. 

At MDLifespan, clinicians evaluate environmental toxin exposure through tools such as the Toxin Test & Talk, which provides insight into individual toxic burden. 

For women planning pregnancy, the MDL Baby protocol was designed to support a healthier internal environment before conception. The protocol may include Advanced Serial Therapeutic Plasma Exchange, a physician-guided procedure that removes circulating inflammatory proteins and environmental toxins from plasma. 

By addressing maternal toxic burden before pregnancy, clinicians aim to reduce fetal toxin exposure and support long-term developmental health. 

As research around prenatal PFAS exposure expands, one conclusion is increasingly clear: environmental health is now a foundational component of preconception planning.